Lassa Fever

OOAS

From Outbreak to Opportunity: Leveraging Lassa Fever Trends from 2018 to 2025 to Strengthen Trial Site Preparedness and Vaccine Acceptance in Ebonyi State, Nigeria

ooas

PROSPECTS OF LASSA FEVER CANDIDATE VACCINES

OOAS

EVALUATION OF SERUM ALBUMIN AS A PROGNOSTIC MARKER IN LASSA FEVER DISEASE.

Design and In-Silico Evaluation of a Novel Multiepitope-based Recombinant DNA Vaccine Candidate against Lassa Hemorrhagic Fever

West African Health Organization
01 BP 153 Bobo-Dioulasso 01 / Burkina Faso
(226) 20 97 01 00 / (226) 20 97 57 75
(226) 20 97 57 72